0000899243-20-014282.txt : 20200526
0000899243-20-014282.hdr.sgml : 20200526
20200526212741
ACCESSION NUMBER: 0000899243-20-014282
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200521
FILED AS OF DATE: 20200526
DATE AS OF CHANGE: 20200526
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hunt Anthony
CENTRAL INDEX KEY: 0001606030
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 20912595
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02452
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-21
0
0000730272
REPLIGEN CORP
RGEN
0001606030
Hunt Anthony
C/O REPLIGEN CORPORATION
41 SEYON ST., BLDG 1, STE 100
WALTHAM
MA
02453
1
1
0
0
Chief Executive Officer
Common Stock
2020-05-21
4
M
0
7916
16.55
A
238157
D
Common Stock
2020-05-21
4
M
0
39037
24.98
A
277194
D
Common Stock
2020-05-21
4
S
0
16496
139.17
D
260698
D
Common Stock
2020-05-21
4
S
0
28980
140.04
D
231718
D
Common Stock
2020-05-21
4
S
0
1377
140.99
D
230341
D
Common Stock
2020-05-21
4
S
0
100
141.58
D
230241
D
Common Stock
2020-05-21
4
M
0
3086
32.40
A
233327
D
Stock Option (Right to Buy)
16.55
2020-05-21
4
M
0
7916
0.00
D
2024-05-05
Common Stock
7916
1
D
Stock Option (Right to Buy)
24.98
2020-05-21
4
M
0
39037
0.00
D
2025-02-26
Common Stock
39037
0
D
Stock Option (Right to Buy)
32.40
2020-05-21
4
M
0
3086
0.00
D
2027-02-23
Common Stock
3086
50154
D
Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on March 11, 2020.
$139.17 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.52 to $139.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$140.04 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.54 to $140.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
$140.99 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.54 to $141.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
This option is currently exercisable.
/s/ Jeffrey P. Leduc (Attorney in Fact)
2020-05-26